NVIDIA BioNeMo™ is a generative AI platform for drug discovery that simplifies and accelerates the training of models using your own data and scaling the deployment of models for drug discovery applications. BioNeMo offers the quickest path to both AI model development and deployment, accelerating the journey to AI-powered drug discovery.
Customize and deploy AI models for 3D protein structure prediction, de novo protein and small molecule generation, property predictions, and molecular docking.
Access pretrained models through cloud APIs or an easy-to-use web interface for interactive inference, visualization, and experimentation.
Experience the ultimate flexibility for experimenting and building enterprise-grade generative AI workflows with GUI and API endpoints on scalable, managed infrastructure.
BioNeMo Training is an end-to-end, optimized training service with state-of-the-art models, data loaders, training workflows, validation in the loop, and enterprise support. Download the BioNeMo Framework from NGC and deploy through the NVIDIA Base Command™ Platform for NVIDIA DGX™ Cloud.
BioNeMo microservices, including BioNeMo Cloud APIs for rapid access to optimized biomolecular AI models, enable users to effortlessly harness generative AI for drug discovery applications. To deploy anywhere and self-host generative AI applications and data, NVIDIA NIM and CUDA-X microservices for NVIDIA-accelerated SDKs and tools, provide the fastest and highest-performing production AI.
NVIDIA DGX Cloud is powered by NVIDIA Base Command Platform, a comprehensive AI workflow management software as a service (SaaS) that spans cloud and on-premises resources. Optimize and train models with the multi-node AI training-as-a-service solution.
Access documentation, tutorials, and community support for BioNeMo.